Is JetBlue The Best Airline Stock?
Following a general trend of improvement among airline stocks, shares…
Sell
41
VTYX Quote, Financials, Valuation and Earnings
Last price:
$8.20
Seasonality move
:
60.24%
Day range:
$8.06 - $8.51
52-week range:
$0.78 - $10.55
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
3.05x
Volume:
1.9M
Avg. volume:
2.1M
1-year change:
235.66%
Market cap:
$584.4M
Revenue:
--
EPS (TTM):
-$1.50
Analysts' Opinion
-
Consensus RatingVentyx Biosciences, Inc. has received a consensus rating of Buy. The company's average rating is a Buy based on 6 Buy ratings, 1 Hold rating, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $15.14, Ventyx Biosciences, Inc. has an estimated upside of 84.9% from its current price of $8.19.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $9.00 representing 100% downside risk from its current price of $8.19.
Fair Value
-
According to the consensus of 7 analysts, Ventyx Biosciences, Inc. has 84.9% upside to fair value with a price target of $15.14 per share.
VTYX vs. S&P 500
-
Over the past 5 trading days, Ventyx Biosciences, Inc. has underperformed the S&P 500 by -5.49% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Ventyx Biosciences, Inc. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Ventyx Biosciences, Inc. has grown year-over-year revenues for 0 quarters straight. In the most recent quarter Ventyx Biosciences, Inc. reported revenues of --.
Earnings Growth
-
Ventyx Biosciences, Inc. has grown year-over-year earnings for 7 quarters straight. In the most recent quarter Ventyx Biosciences, Inc. reported earnings per share of -$0.32.
Enterprise value:
401.8M
EV / Invested capital:
2.00x
Price / LTM sales:
--
EV / EBIT:
--
EV / Revenue:
--
PEG ratio (5yr expected):
--
EV / Free cash flow:
-4.57x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
--
Gross Profit (TTM):
-$1.3M
Return On Assets:
-41.82%
Net Income Margin (TTM):
--
Return On Equity:
-45.75%
Return On Invested Capital:
-43.77%
Operating Margin:
--
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Income Statement | ||||||
| Revenue | -- | -- | -- | -- | -- | |
| Gross Profit | -$688K | -$1.4M | -$1.3M | -$309K | -$326K | |
| Operating Income | -$196.2M | -$164.2M | -$116.4M | -$38.6M | -$24.9M | |
| EBITDA | -$195.5M | -$162.7M | -$115.1M | -$38.2M | -$24.5M | |
| Diluted EPS | -$3.12 | -$2.37 | -$1.50 | -$0.50 | -$0.32 | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $145.7M | $418.4M | $308.1M | $289.4M | $201.1M | |
| Total Assets | $148.7M | $420.4M | $321.7M | $301.1M | $211.5M | |
| Current Liabilities | $11.8M | $35.7M | $26.2M | $12.3M | $11.3M | |
| Total Liabilities | $236.3M | $36.9M | $38.1M | $22.3M | $20.1M | |
| Total Equity | -$87.6M | $383.5M | $283.6M | $278.8M | $191.4M | |
| Total Debt | $224.5M | $1.3M | $11.9M | $10M | $8.8M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -$162.1M | -$159.3M | -$87.8M | -$35.5M | -$17.5M | |
| Cash From Investing | -$86M | $41.6M | $57.7M | $29.2M | $17.1M | |
| Cash From Financing | $42.4M | $122.7M | $246K | $26.9M | $203K | |
| Free Cash Flow | -$162.5M | -$159.7M | -$87.9M | -$35.5M | -$17.6M | |
VTYX
Sector
Market Cap
$584.4M
$28.6M
Price % of 52-Week High
77.65%
51.66%
Dividend Yield
0%
0%
Shareholder Yield
0%
-1.34%
1-Year Price Total Return
235.66%
-20.19%
Beta (5-Year)
--
0.519
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Sell
Level
$8.41
200-day SMA
Buy
Level
$3.37
Bollinger Bands (100)
Buy
Level
2.13 - 7.89
Chaikin Money Flow
Sell
Level
-2.6M
20-day SMA
Sell
Level
$9.10
Relative Strength Index (RSI14)
Sell
Level
47.02
ADX Line
Sell
Level
23.47
Williams %R
Neutral
Level
-79.9864
50-day SMA
Buy
Level
$7.33
MACD (12, 26)
Buy
Level
1.11
25-day Aroon Oscillator
Sell
Level
-20
On Balance Volume
Neutral
Level
2.3M
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (0.1903)
Sell
CA Score
(Annual)
Level (-1.0606)
--
Beneish M-Score
(Annual)
Level (--)
Buy
Momentum Score
Level (10)
Sell
Ohlson Score
Level (8.9028)
--
Piotroski F Score
(Annual)
Level (--)
Sell
Quality Ratio Score
Level (1)
Buy
Fundamental Score
Level (3)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Ventyx Biosciences, Inc. engages in developing novel small molecule therapeutics for the treatment of autoimmune diseases. Its clinical stage pipeline includes VTX958, a Phase 1 allosteric TYK2 inhibitor for the treatment of a broad range of autoimmune diseases, VTX002, a Phase 2-ready S1P1 receptor modulator for the treatment of ulcerative colitis, and VTX2735, a Phase 1-ready peripheral inhibitor of the NLRP3 inflammasome, which is a mediator of multiple inflammatory conditions. The company was founded by Raju S. Mohan on November 21, 2018 and is headquartered in San Diego, CA.
Stock Forecast FAQ
In the current month, VTYX has received 6 Buy ratings 1 Hold ratings, and 0 Sell ratings. The VTYX average analyst price target in the past 3 months is $15.14.
-
Where Will Ventyx Biosciences, Inc. Stock Be In 1 Year?
According to analysts, the consensus estimate is that Ventyx Biosciences, Inc. share price will rise to $15.14 per share over the next 12 months.
-
What Do Analysts Say About Ventyx Biosciences, Inc.?
Analysts are divided on their view about Ventyx Biosciences, Inc. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Ventyx Biosciences, Inc. is a Sell and believe this share price will drop from its current level to $9.00.
-
What Is Ventyx Biosciences, Inc.'s Price Target?
The price target for Ventyx Biosciences, Inc. over the next 1-year time period is forecast to be $15.14 according to 7 Wall Street analysts, 6 of them rate the stock a Buy, 0 rate the stock a Sell, and 1 analyst rates the stock a Hold.
-
Is VTYX A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Ventyx Biosciences, Inc. is a Buy. 6 of 7 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of VTYX?
You can purchase shares of Ventyx Biosciences, Inc. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Ventyx Biosciences, Inc. shares.
-
What Is The Ventyx Biosciences, Inc. Share Price Today?
Ventyx Biosciences, Inc. was last trading at $8.20 per share. This represents the most recent stock quote for Ventyx Biosciences, Inc.. Yesterday, Ventyx Biosciences, Inc. closed at $8.19 per share.
-
How To Buy Ventyx Biosciences, Inc. Stock Online?
In order to purchase Ventyx Biosciences, Inc. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Get VTYX Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
VTYX
Sector
P/E ratio
--
24.09x
PEG ratio
--
-0.01x
P/B ratio
3.05x
1.84x
Price / LTM sales
--
1.60x
Growth Metrics
VTYX
Sector
Revenue growth
--
4.73%
Earnings growth
35.81%
11.06%
Revenue (5-year growth)
--
6.5%
Earnings forecast
-$0.45
-$0.20
Profitability
VTYX
Sector
Profitability FY 2024
-$1.3M
$3.6M
Return on invested capital
-43.77%
-31.16%
Return on assets
-41.82%
-27.72%
Return on equity
-45.75%
-36.97%
Earnings Date
Last Earnings Date
Nov
6
Next Earnings Date
Feb
26
Estimated Next Earnings Date
Feb
5
Balance Sheet
VTYX
Sector
Total cash
$192.6M
$27M
Short term investments
$190.1M
$26M
Total assets
$278.7M
$79.7M
Long term debt
$8.8M
$3.5M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Why Did Netflix Buy Warner Bros?
Following a bidding war, Netflix (NASDAQ:NFLX) has announced its intention…
Why Did SoFi Stock Drop?
Fintech platform SoFi (NASDAQ:SOFI) has stumbled in recent days, selling…
Stock Ideas
Sell
47
Is NVDA Stock a Buy?
Market Cap: $4.3T
P/E Ratio: 60x
Buy
58
Is AAPL Stock a Buy?
Market Cap: $4.1T
P/E Ratio: 37x
Buy
73
Is GOOG Stock a Buy?
Market Cap: $3.7T
P/E Ratio: 39x
Alerts
Buy
80
FEIM alert for Dec 13
Frequency Electronics, Inc. [FEIM] is up 28.76% over the past day.
Buy
57
MOD alert for Dec 13
Modine Manufacturing Co. [MOD] is down 15.32% over the past day.
Sell
42
OKLO alert for Dec 13
Oklo, Inc. [OKLO] is down 14.91% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
